Customised skid-based equipment for pharma and biotech
ZETA designs and delivers customised skid systems and process equipment for pharmaceutical and biotech manufacturing. The end-to-end approach includes engineering, automation, procurement, fabrication, installation, and qualification—all provided from a single source. This ensures faster execution, regulatory alignment, and equipment that is purpose-built for reliable, high-performance operations.
Tailored for operational excellence
Each skid or system is engineered for performance, compliance, and seamless integration into production environments. Equipment is designed to meet current operational needs while remaining adaptable for future requirements. From upstream to downstream processes, ZETA provides comprehensive coverage across the entire production workflow.
Capabilities include:
- Upstream systems: For any organism (E. coli, CHO, yeast), any scale (<1L to >100kL), and any process type (batch, fed-batch, perfusion)
- Downstream systems: Centrifuges, homogenisers, chromatography, filtration, continuous DSP
- Fractionation systems: Integrated solutions with smart buffer systems and filter press integration
- Preparation systems: Buffer and media preparation, emulsion systems, inline dilution and conditioning
- Clean media & CIP/SIP systems: Tailor-made, CAPEX- and OPEX-optimised
Excellence at every stage
ZETA combines decades of skid fabrication experience with deep process expertise. Interdisciplinary teams include certified welding engineers, ASME committee members, automation specialists, and CQV experts to ensure precision at every step. With over 2,000,000 project hours annually, production of more than 200 process vessels (0.5L to 100,000L), and 37,000 m² of manufacturing space across six sites in Austria, the Czech Republic, and India, ZETA has the capacity and expertise to deliver at scale.
More than a supplier
ZETA’s deep understanding of the processes behind the equipment allows it to act as a strategic partner – driving innovation, challenging ideas, and co-creating production processes for the next generation of pharmaceutical and biotech manufacturing.